GlassScriptPhysician profile
Sreeharsha Nandyala
NPI 1225419732
$8,826.53
in general payments reported to CMS, 2019-2025
12 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,578 · 2022: $4,634 · 2023: $2,247 · 2024: $258 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,365 · Food and Beverage: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,365.46 |
| Food and Beverage | $1,249.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,950.53 | 2021-2023 | Mazor X System, Atlas Cable System |
| Globus Medical, INC. | $2,682.93 | 2022-2023 | Excelsiusgps Robotic Navigation System |
| Zimvie INC. | $1,037.02 | 2023 | |
| Synthes Gmbh | $733.60 | 2021 | |
| Stryker Corporation | $611.30 | 2021-2024 | Everest Spinal System |
| Alphatec Spine, INC | $165.44 | 2023 | |
| Nexxt Spine LLC | $158.66 | 2024 | Nexxt Matrixx Sa Alif Systems |
| Nevro Corp. | $149.76 | 2022 | |
| Acera Surgical, INC. | $129.74 | 2023 | Restrata Wound Matrix |
| Boston Scientific Corporation | $110.12 | 2025 | General - Pain Management |
| Depuy Synthes Sales INC. | $64.51 | 2023 | Viper |
| Bioventus LLC | $32.92 | 2024 | Bonescalpel & Sonicone (O.R.) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sreeharsha Nandyala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.